Most people are aware of the widely known and visible side effects of chemotherapy like hair loss and nausea. There are also common but less visible side effects of chemotherapy. Febrile neutropenia (FN) is a serious side effect of chemotherapy for breast and other cancers.
Watch this short video to learn more about managing the side effects of chemotherapy.
The spring 2016 edition of Network News is now available online!
Inside you’ll find many supportive articles on topics such as telling your child you have breast cancer, caring for our caregivers, depression and anxiety, and hypnotherapy.
You'll also learn about inflammatory breast cancer from a patient with this rare form of the disease.
We hope that these articles will make your life as a breast cancer patient or survivor a little easier with the knowledge that we at CBCN and the wider breast cancer community fully support you in your cancer journey.
Opportunity to inform industry survey on patient/caregiver awareness and perceptions of subsequent entry biologics (SEBs)
A new survey, funded by a major pharmaceutical company involved in cancer treatment, is looking for participants to answer questions regarding the patient/caregiver experience of biologic and subsequent entry biologic therapies.
The objective of this market research is to understand patient/caregiver awareness, perceptions and the importance of issues relating to new developments in cancer treatment. Results from this survey will help inform future educational initiatives associated with new cancer treatments.
June 18, 2016: Join us for the 3rd Annual Pink Ribbon Project fundraiser in Brooks, AB!
Thanks to the Full Circle Foundation for Wellness, we are proud to be a part of the 3rd Annual Pink Ribbon Project taking place on Saturday, June 18, 2016. In support of the Canadian Breast Cancer Network and the Canadian Breast Cancer Foundation, The Pink Ribbon Project will be a social gathering that your friends, colleagues and clients will want to be a part of!
Tickets are on sale now. For more information, click here.